MERIT – A phase II marker identification trial for TarcevaTM in second line NSCLC patients

View Statistics Email Alert RSS Feed

Grant Data
Project Title
MERIT – A phase II marker identification trial for TarcevaTM in second line NSCLC patients
Principal Investigator
Professor Ho, James Chung Man   (Principal Investigator (PI))
Duration
27
Start Date
2005-07-06
Completion Date
2007-10-05
Amount
154641
Conference Title
MERIT – A phase II marker identification trial for TarcevaTM in second line NSCLC patients
Keywords
MERIT
Discipline
Cancer
HKU Project Code
N/A
Grant Type
F Hoffmann-La Roche and Co. Ltd. - General Award
Funding Year
2005
Status
Completed